GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

Pharma giant Glaxosmithkline, which has major operations in Upper Providence and West Point, is partnering with China-based ...

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

The deal, which focuses first on a COPD drug GSK believes holds “best-in-class” potential, could involve a dozen medicines ...

Jiangsu Hengrui Pharmaceuticals' shares surged 10% to a 4-year high after licensing HRS-9821 and 11 programs to ...

GSK is paying $500M upfront for rights to a series of Hengrui drugs, the latest case of a pharma company looking to a Chinese ...

Hengrui Pharma partners with GSK to develop 12 innovative medicines, boosting globalization for Hengrui and expanding GSK's oncology and RI&I pipeline.

(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US regulator. The London-based pharmaceutical firm ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Each year, 1·3 million people die from viral hepatitis, and mortality is increasing.1 This World Hepatitis Day, all stakeholders must break down the barriers to hepatitis elimination, including ending ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

A two-week program at North Carolina Central University gives attendees a $1,000 stipend, field trips to local businesses, ...